Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Colitis, Microscopic

ClinicalTrials.gov lists 27 trials for Colitis, Microscopic or a narrower condition beneath it. Dr. Falk Pharma GmbH has the most among industry and government lead sponsors, with 3.

MeSH D046728 Digestive System Diseases C06 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2 Phase 2 3 Phase 2/3 Phase 2/3 2 Phase 3 Phase 3 7 Not applicable Not applicable 5 Observational Observational 9 Phase 1 Phase 1 1 Phase 2 Phase 2 3 Phase 2/3 Phase 2/3 2 Phase 3 Phase 3 7 Not applicable Not applicable 5 Observational Observational 9

Trials per phase

22 of the 27 trials are tagged with Colitis, Microscopic itself; the rest are tagged with a narrower condition beneath it.

Get the Colitis, Microscopic report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Colitis, Microscopic trials start? (18)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 3

2001: 1 trials (Not applicable 1) 2002: 1 trials (Phase 3 1) 2003: 1 trials (Phase 2/3 1) 2004: 2 trials (Phase 3 2) 2007: 2 trials (Phase 3 1, Phase 2/3 1) 2008: 1 trials (Phase 3 1) 2009: 1 trials (Not applicable 1) 2010: 1 trials (Phase 3 1) 2014: 1 trials (Observational 1) 2015: 2 trials (Observational 1, Not applicable 1) 2016: 1 trials (Observational 1) 2017: 1 trials (Not applicable 1) 2018: 3 trials (Observational 1, Phase 3 1, Phase 2 1) 2021: 1 trials (Not applicable 1) 2022: 3 trials (Observational 3) 2023: 1 trials (Phase 1 1) 2024: 2 trials (Observational 1, Phase 2 1) 2025: 2 trials (Observational 1, Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2025 2
2024 2
2023 1
2022 3
2021 1
2018 3
2017 1
2016 1
2015 2
2014 1

No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Colitis, Microscopic trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2 3
Phase 2/3 2
Phase 3 7
Not applicable 5
Observational 9

How many Colitis, Microscopic trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 2
Enrolling by invitation 1
Completed 11
Terminated 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Colitis, Microscopic trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Dr. Falk Pharma GmbH 3
Sanofi 1

Which drugs are being tested for Colitis, Microscopic? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Natrol 1

Interventions as named in the registry (8)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Budesonide EC 8
MMX Mesalamine 3
Fecal Microbiota Transplantation 2
Rifaximine 2
Budesonide controlled ileal release (CR) capsules 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Colitis, Microscopic? (16)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Colonic bacterial diversity and dysbiosis in active microscopic colitis as compared to chronic diarrhoea and healthy controls: effect of polyethylene glycol after bowel lavage for colonoscopy. BMC gastroenterology 2022 Yes
Obesity is associated with decreased risk of microscopic colitis in women. World journal of gastroenterology 2022 Yes
The overlap between irritable bowel syndrome and organic gastrointestinal diseases. The lancet. Gastroenterology & hepatology 2021 Yes
Microscopic Colitis Is Characterized by Intestinal Dysbiosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Yes
Usefulness of fecal calprotectin as a biomarker of microscopic colitis in a cohort of patients with chronic watery diarrhoea of functional characteristics. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019 Yes

Sub-conditions in MeSH (2)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Browse all condition evidence pages